Patent · US Expired

Methods for treating bulimia using optically pure (−) norcisapride

US6559165B1 · kind B1 · utility

11Cited by
37References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 2000
Grant dateMay 6, 2003
Priority date—
Expiry dateNov 28, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for the prevention, treatment, or management of apnea, apnea disorders, bulimia nervosa, irritable bowel syndrome, urinary incontinence, bradycardia, bradyarrhythmia, syncope, other disorders, or symptoms thereof using (−) norcisapride, or a pharmaceutically acceptable salt thereof, substantially free of its (+) stereoisomer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.